Regeneron Pharmaceuticals Inc (REGN)
893.50
-7.69
(-0.85%)
USD |
NASDAQ |
Apr 18, 16:00
893.71
+0.21
(+0.02%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Return Level: 893.50 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 893.50 |
April 17, 2024 | 901.19 |
April 16, 2024 | 894.14 |
April 15, 2024 | 898.56 |
April 12, 2024 | 904.70 |
April 11, 2024 | 920.32 |
April 10, 2024 | 936.20 |
April 09, 2024 | 943.89 |
April 08, 2024 | 938.48 |
April 05, 2024 | 942.70 |
April 04, 2024 | 937.02 |
April 03, 2024 | 950.95 |
April 02, 2024 | 954.68 |
April 01, 2024 | 969.31 |
March 28, 2024 | 962.49 |
March 27, 2024 | 966.30 |
March 26, 2024 | 963.55 |
March 25, 2024 | 961.09 |
March 22, 2024 | 967.24 |
March 21, 2024 | 968.01 |
March 20, 2024 | 966.96 |
March 19, 2024 | 963.66 |
March 18, 2024 | 959.92 |
March 15, 2024 | 964.47 |
March 14, 2024 | 959.04 |
Date | Value |
---|---|
March 13, 2024 | 965.47 |
March 12, 2024 | 970.57 |
March 11, 2024 | 964.44 |
March 08, 2024 | 968.83 |
March 07, 2024 | 973.31 |
March 06, 2024 | 972.10 |
March 05, 2024 | 965.21 |
March 04, 2024 | 971.19 |
March 01, 2024 | 982.82 |
February 29, 2024 | 966.09 |
February 28, 2024 | 987.61 |
February 27, 2024 | 993.35 |
February 26, 2024 | 989.28 |
February 23, 2024 | 981.20 |
February 22, 2024 | 964.89 |
February 21, 2024 | 952.84 |
February 20, 2024 | 946.87 |
February 16, 2024 | 948.05 |
February 15, 2024 | 954.73 |
February 14, 2024 | 947.82 |
February 13, 2024 | 940.48 |
February 12, 2024 | 947.06 |
February 09, 2024 | 953.42 |
February 08, 2024 | 946.43 |
February 07, 2024 | 938.49 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
273.46
Minimum
Sep 27 2019
993.35
Maximum
Feb 27 2024
607.80
Average
612.05
Median
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 393.48 |
Eli Lilly and Co | 2147.17 |
CytomX Therapeutics Inc | 1.73 |
Pfizer Inc | 86.78 |
Puma Biotechnology Inc | 4.99 |